Evidence map›Paper›PMID 22249028›Full record

ArticleThe international journal of biochemistry & cell biology2012

Murine embryonic stem cell-derived hepatocytes correct metabolic liver disease after serial liver repopulation.

Zhi-Ying He, Li Deng, Yang-Fang Li, Dao Xiang, Jun-Kai Hu, Yuan-Xiao Chen, Min-Jun Wang, Fei Chen, Chang-Cheng Liu, Wen-Lin Li and 6 more

Abstract read
In one paragraph

Article in The international journal of biochemistry & cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Generation of functional hepatic cells from pluripotent stem cells.Journal of stem cell research & therapy · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Zhi-Ying HeDepartment of Cell Biology, Second Military Medical University, Shanghai, China.
Li Deng
Yang-Fang Li
Dao Xiang
Jun-Kai Hu
Yuan-Xiao Chen
Min-Jun Wang
Fei Chen
Chang-Cheng Liu
Wen-Lin Li
Xiao-Yuan Zi
Xia Wu
Guang-Peng Li
Kirk J Wangensteen
Yi-Ping Hu
Xin Wang
Second Military Medical University · CNChinese Academy of Sciences · CNInner Mongolia University · CNKunming Medical University · CNUniversity of Pennsylvania · US

Funding

FoxM1 in Hepatocytes During Liver RepopulationR21DK074561 · NIDDK · UNIVERSITY OF MINNESOTA · PI WANG, XIN · 2006 to 2007
$404k
Generating a Human Hepatocyte-repopulated MouseR03AI065565 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WANG, XIN · 2005 to 2006
$148k
NIAID NIH HHS AI065565NIAID NIH HHS R03 AI065565NIDDK NIH HHS DK074561NIDDK NIH HHS R21 DK074561
6 · The paper itself

Abstract

Although embryonic stem (ES) cell-derived hepatocytes have the capacity for liver engraftment and repopulation, their in vivo hepatic function has not been analyzed yet. We aimed to determine the metabolic function and therapeutic action of ES cell-derived hepatocytes after serial liver repopulations in fumaryl acetoacetate hydrolase knockout (Fah(-/-)) mice. Albumin expressing (Alb(+)) cells were obtained by hepatic differentiation of ES cells using two frequently reported methods. After transplantation, variable levels of liver repopulation were found in Fah(-/-) mice recipients. FAH expressing (FAH(+)) hepatocytes were found either as single cells or as nodules with multiple hepatocytes. After serial transplantation, the proportion of the liver that was repopulated by the re-transplanted FAH(+) hepatocytes increased significantly. ES cell-derived FAH(+) hepatocytes were found in homogenous nodules and corrected the liver metabolic disorder of Fah(-/-) recipients and rescued them from death. ES cell-derived hepatocytes had normal karyotype, hepatocytic morphology and metabolic function both in vitro and in vivo. In conclusion, ES cell-derived hepatocytes were capable of liver repopulation and correction of metabolic defects after serial transplantation. Our results are an important piece of evidence to support future clinical applications of ES cell-derived hepatocytes in treating liver diseases.

Indexed as

AlbuminsAnimalsCell DifferentiationCell SeparationEmbryonic Stem CellsHepatocytesHydrolasesLiverLiver DiseasesMetabolic DiseasesMiceStem Cell TransplantationTime FactorsAlbuminsfumarylacetoacetaseHydrolases

Identifiers

PMID22249028
PMCPMC3314493
OpenAlexW2011290357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.